INSPIRE MEDICAL SYSTEMS INC (INSP) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:INSP - US4577301090 - Common Stock
95.65 USD
+0.67 (+0.71%)
95.65 USD
0 (0%)
Taking everything into account, INSP scores 6 out of 10 in our fundamental rating. INSP was compared to 185 industry peers in the Health Care Equipment & Supplies industry. INSP has an excellent financial health rating, but there are some minor concerns on its profitability. INSP is not overvalued while it is showing excellent growth. This is an interesting combination. With these ratings, INSP could be worth investigating further for growth investing!.
1. Profitability
1.1 Basic Checks
In the past year INSP was profitable.
INSP had a positive operating cash flow in the past year.
INSP had negative earnings in 4 of the past 5 years.
In multiple years INSP reported negative operating cash flow during the last 5 years.
1.2 Ratios
With an excellent Return On Assets value of 5.52%, INSP belongs to the best of the industry, outperforming 82.16% of the companies in the same industry.
Looking at the Return On Equity, with a value of 6.69%, INSP belongs to the top of the industry, outperforming 81.08% of the companies in the same industry.
INSP's Return On Invested Capital of 4.82% is fine compared to the rest of the industry. INSP outperforms 75.68% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.52% | ||
| ROE | 6.69% | ||
| ROIC | 4.82% |
ROA(3y)-1.48%
ROA(5y)-7.81%
ROE(3y)-1.66%
ROE(5y)-9.65%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
INSP has a better Profit Margin (5.05%) than 77.30% of its industry peers.
INSP's Operating Margin of 4.16% is fine compared to the rest of the industry. INSP outperforms 68.65% of its industry peers.
INSP's Gross Margin of 84.92% is amongst the best of the industry. INSP outperforms 94.05% of its industry peers.
In the last couple of years the Gross Margin of INSP has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.16% | ||
| PM (TTM) | 5.05% | ||
| GM | 84.92% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.41%
GM growth 5Y0.33%
2. Health
2.1 Basic Checks
INSP has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
INSP has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, INSP has more shares outstanding
INSP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
INSP has an Altman-Z score of 13.27. This indicates that INSP is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 13.27, INSP belongs to the top of the industry, outperforming 92.43% of the companies in the same industry.
There is no outstanding debt for INSP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 13.27 |
ROIC/WACC0.55
WACC8.79%
2.3 Liquidity
INSP has a Current Ratio of 5.29. This indicates that INSP is financially healthy and has no problem in meeting its short term obligations.
INSP's Current ratio of 5.29 is fine compared to the rest of the industry. INSP outperforms 80.00% of its industry peers.
INSP has a Quick Ratio of 4.01. This indicates that INSP is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 4.01, INSP is in the better half of the industry, outperforming 74.59% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.29 | ||
| Quick Ratio | 4.01 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 90.65% over the past year.
Looking at the last year, INSP shows a quite strong growth in Revenue. The Revenue has grown by 16.81% in the last year.
INSP shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 57.78% yearly.
EPS 1Y (TTM)90.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-43.33%
Revenue 1Y (TTM)16.81%
Revenue growth 3Y50.95%
Revenue growth 5Y57.78%
Sales Q2Q%10.49%
3.2 Future
The Earnings Per Share is expected to grow by 21.35% on average over the next years. This is a very strong growth
Based on estimates for the next years, INSP will show a quite strong growth in Revenue. The Revenue will grow by 11.59% on average per year.
EPS Next Y-45.95%
EPS Next 2Y0.41%
EPS Next 3Y15.46%
EPS Next 5Y21.35%
Revenue Next Year13.16%
Revenue Next 2Y12.49%
Revenue Next 3Y12.39%
Revenue Next 5Y11.59%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 46.89, INSP can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of INSP indicates a somewhat cheap valuation: INSP is cheaper than 69.19% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of INSP to the average of the S&P500 Index (26.59), we can say INSP is valued expensively.
INSP is valuated quite expensively with a Price/Forward Earnings ratio of 54.84.
Compared to the rest of the industry, the Price/Forward Earnings ratio of INSP indicates a somewhat cheap valuation: INSP is cheaper than 68.11% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of INSP to the average of the S&P500 Index (24.03), we can say INSP is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 46.89 | ||
| Fwd PE | 54.84 |
4.2 Price Multiples
INSP's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. INSP is cheaper than 67.03% of the companies in the same industry.
INSP's Price/Free Cash Flow ratio is rather cheap when compared to the industry. INSP is cheaper than 80.54% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 28.13 | ||
| EV/EBITDA | 45.55 |
4.3 Compensation for Growth
A more expensive valuation may be justified as INSP's earnings are expected to grow with 15.46% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.41%
EPS Next 3Y15.46%
5. Dividend
5.1 Amount
No dividends for INSP!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
95.65
+0.67 (+0.71%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners110.83%
Inst Owner Change-6.74%
Ins Owners0.75%
Ins Owner Change0.1%
Market Cap2.78B
Revenue(TTM)882.62M
Net Income(TTM)44.56M
Analysts79.23
Price TargetN/A
Short Float %12.13%
Short Ratio2.39
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)193.12%
Min EPS beat(2)114.53%
Max EPS beat(2)271.71%
EPS beat(4)4
Avg EPS beat(4)144.95%
Min EPS beat(4)54.07%
Max EPS beat(4)271.71%
EPS beat(8)8
Avg EPS beat(8)284.67%
EPS beat(12)12
Avg EPS beat(12)208.03%
EPS beat(16)16
Avg EPS beat(16)165.01%
Revenue beat(2)0
Avg Revenue beat(2)-0.43%
Min Revenue beat(2)-0.69%
Max Revenue beat(2)-0.17%
Revenue beat(4)1
Avg Revenue beat(4)-0.14%
Min Revenue beat(4)-0.84%
Max Revenue beat(4)1.13%
Revenue beat(8)4
Avg Revenue beat(8)0.25%
Revenue beat(12)7
Avg Revenue beat(12)1.47%
Revenue beat(16)11
Avg Revenue beat(16)3.25%
PT rev (1m)0.77%
PT rev (3m)-13.55%
EPS NQ rev (1m)-1.28%
EPS NQ rev (3m)-0.04%
EPS NY rev (1m)81.38%
EPS NY rev (3m)83.02%
Revenue NQ rev (1m)-0.15%
Revenue NQ rev (3m)-0.83%
Revenue NY rev (1m)0.12%
Revenue NY rev (3m)0.05%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 46.89 | ||
| Fwd PE | 54.84 | ||
| P/S | 3.15 | ||
| P/FCF | 28.13 | ||
| P/OCF | 20.79 | ||
| P/B | 4.17 | ||
| P/tB | 4.17 | ||
| EV/EBITDA | 45.55 |
EPS(TTM)2.04
EY2.13%
EPS(NY)1.74
Fwd EY1.82%
FCF(TTM)3.4
FCFY3.56%
OCF(TTM)4.6
OCFY4.81%
SpS30.37
BVpS22.93
TBVpS22.93
PEG (NY)N/A
PEG (5Y)N/A
Graham Number32.44
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.52% | ||
| ROE | 6.69% | ||
| ROCE | 5.27% | ||
| ROIC | 4.82% | ||
| ROICexc | 8.98% | ||
| ROICexgc | 8.98% | ||
| OM | 4.16% | ||
| PM (TTM) | 5.05% | ||
| GM | 84.92% | ||
| FCFM | 11.2% |
ROA(3y)-1.48%
ROA(5y)-7.81%
ROE(3y)-1.66%
ROE(5y)-9.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.41%
GM growth 5Y0.33%
F-Score8
Asset Turnover1.09
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 276.46% | ||
| Cap/Sales | 3.95% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 270.95% | ||
| Profit Quality | 221.78% | ||
| Current Ratio | 5.29 | ||
| Quick Ratio | 4.01 | ||
| Altman-Z | 13.27 |
F-Score8
WACC8.79%
ROIC/WACC0.55
Cap/Depr(3y)638.93%
Cap/Depr(5y)518.49%
Cap/Sales(3y)3.63%
Cap/Sales(5y)3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)90.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-43.33%
EPS Next Y-45.95%
EPS Next 2Y0.41%
EPS Next 3Y15.46%
EPS Next 5Y21.35%
Revenue 1Y (TTM)16.81%
Revenue growth 3Y50.95%
Revenue growth 5Y57.78%
Sales Q2Q%10.49%
Revenue Next Year13.16%
Revenue Next 2Y12.49%
Revenue Next 3Y12.39%
Revenue Next 5Y11.59%
EBIT growth 1Y172.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year638.4%
EBIT Next 3Y118.04%
EBIT Next 5Y73.68%
FCF growth 1Y1118.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y401.46%
OCF growth 3YN/A
OCF growth 5YN/A
INSPIRE MEDICAL SYSTEMS INC / INSP FAQ
Can you provide the ChartMill fundamental rating for INSPIRE MEDICAL SYSTEMS INC?
ChartMill assigns a fundamental rating of 6 / 10 to INSP.
What is the valuation status of INSPIRE MEDICAL SYSTEMS INC (INSP) stock?
ChartMill assigns a valuation rating of 4 / 10 to INSPIRE MEDICAL SYSTEMS INC (INSP). This can be considered as Fairly Valued.
Can you provide the profitability details for INSPIRE MEDICAL SYSTEMS INC?
INSPIRE MEDICAL SYSTEMS INC (INSP) has a profitability rating of 5 / 10.
Can you provide the financial health for INSP stock?
The financial health rating of INSPIRE MEDICAL SYSTEMS INC (INSP) is 8 / 10.
What is the expected EPS growth for INSPIRE MEDICAL SYSTEMS INC (INSP) stock?
The Earnings per Share (EPS) of INSPIRE MEDICAL SYSTEMS INC (INSP) is expected to decline by -45.95% in the next year.